LXEO Earnings Lexeo Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–15 of 15
| Q1 2026 | 2026-03-31 | -0.25 | 2026-05-11 | 10-Q |
| FY 2025 | 2025-12-31 | -1.86 | 2026-03-30 | 10-K |
| Q3 2025 | 2025-09-30 | -1.72 | 2025-11-05 | 10-Q |
| Q2 2025 | 2025-06-30 | -1.53 | 2025-08-14 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.99 | 2026-05-11 | 10-Q |
| FY 2025 | 2024-12-31 | -3.09 | 2026-03-30 | 10-K |
| Q3 2025 | 2024-09-30 | -2.31 | 2025-11-05 | 10-Q |
| Q2 2025 | 2024-06-30 | -1.41 | 2025-08-14 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.77 | 2025-05-12 | 10-Q |
| FY 2024 | 2023-12-31 | -12.40 | 2025-03-24 | 10-K |
| Q3 2024 | 2023-09-30 | -32.24 | 2024-11-13 | 10-Q |
| Q2 2024 | 2023-06-30 | -19.87 | 2024-08-12 | 10-Q |
| Q1 2024 | 2023-03-31 | -11.58 | 2024-05-09 | 10-Q |
| FY 2023 | 2022-12-31 | -36.36 | 2024-03-11 | 10-K |
| Q3 2023 | 2022-09-30 | -27.50 | 2023-12-11 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.